Compare PFAI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFAI | ICCM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Canada | Israel |
| Employees | 7 | N/A |
| Industry | Farming/Seeds/Milling | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6M | 41.4M |
| IPO Year | N/A | 2013 |
| Metric | PFAI | ICCM |
|---|---|---|
| Price | $3.71 | $0.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 6.0K | ★ 509.1K |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $0.24 |
| 52 Week High | $4.93 | $1.40 |
| Indicator | PFAI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 51.15 | 27.57 |
| Support Level | $3.50 | N/A |
| Resistance Level | $4.10 | $0.74 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 35.00 | 0.00 |
Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.